Since 1998, OCRA has awarded 349 grants totaling over $97 million for ovarian cancer research to top scientists at 79 leading medical centers. We invest our dollars wisely, supporting the best ovarian cancer research in the nation.
OCRA-funded projects have led to significant advances in such areas as early detection, diagnosis, genetics, prevention, treatments, and enhancing quality of life.
In just the past year, OCRA funded researchers have:
- identified a new therapeutic approach for patients with clear cell ovarian cancer
- found two new genetic variants linked to ovarian cancer
- better understood the link between hypertension and ovarian cancer
- discovered how a new gene mutation may spur ovarian cancer growth
- found a new target for future immunotherapy studies
The results of OCRA-supported research projects have been published in some of the world’s most prestigious journals, such as: Gynecologic Oncology, Lancet Oncology, New England Journal of Medicine, Cancer Research, Clinical Cancer Research, Journal of Clinical Oncology, Science Translational Medicine, Cancer Discovery and Nature.